BR9915695A - Diagnóstico de doença desmielinizante ou espongiforme - Google Patents

Diagnóstico de doença desmielinizante ou espongiforme

Info

Publication number
BR9915695A
BR9915695A BR9915695-4A BR9915695A BR9915695A BR 9915695 A BR9915695 A BR 9915695A BR 9915695 A BR9915695 A BR 9915695A BR 9915695 A BR9915695 A BR 9915695A
Authority
BR
Brazil
Prior art keywords
demyelinating
diagnosis
disease
spongiform
spongiform disease
Prior art date
Application number
BR9915695-4A
Other languages
English (en)
Inventor
Alan Ebringer
Original Assignee
King S College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King S College filed Critical King S College
Publication of BR9915695A publication Critical patent/BR9915695A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <D> "DIAGNóSTICO DE DOENçA DESMIELINIZANTE OU ESPONGIFORME"<D>. Um processo para diagnóstico de doença espongiforme ou de doença desmielinizante em vertebrados, incluindo BSE, MS e CJD, que compreende o ensaio de uma amostra biológica para anticorpos que se ligam à mielina e/ou a neurofilamentos ou a uma ou mais partes antigênicas (imunogênicas) dos mesmos.
BR9915695-4A 1998-11-26 1999-11-25 Diagnóstico de doença desmielinizante ou espongiforme BR9915695A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9825948.4A GB9825948D0 (en) 1998-11-26 1998-11-26 Diagnosis of spongiform disease
PCT/GB1999/003936 WO2000031545A1 (en) 1998-11-26 1999-11-25 Diagnosis of demyelinating or spongiform disease

Publications (1)

Publication Number Publication Date
BR9915695A true BR9915695A (pt) 2001-08-14

Family

ID=10843113

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915695-4A BR9915695A (pt) 1998-11-26 1999-11-25 Diagnóstico de doença desmielinizante ou espongiforme

Country Status (10)

Country Link
EP (1) EP1133696A1 (pt)
JP (1) JP2002530679A (pt)
CN (1) CN1163755C (pt)
AU (1) AU764960B2 (pt)
BR (1) BR9915695A (pt)
CA (1) CA2350658A1 (pt)
GB (1) GB9825948D0 (pt)
MX (1) MXPA01005158A (pt)
NZ (1) NZ512335A (pt)
WO (1) WO2000031545A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100947577B1 (ko) 2000-06-26 2010-03-15 엔씨 메디컬 리서치 가부시키가이샤 신경계 세포로 분화할 수 있는 세포를 포함하는 세포분획
DE10112097A1 (de) * 2001-03-12 2002-10-02 Ingrid Menzel Verfahren zur Erfassung der Pathogenese und/oder zur Diagnose von 'transmissiblen spongiformen Enzephalopathien
EP1442300A2 (en) * 2001-11-09 2004-08-04 King's College London Diagnosis demyelinating or spongiform disease
CA2532130C (en) * 2003-09-20 2016-07-19 Electrophoretics Limited Diagnostic method for brain damage-related disorders
JP6156889B2 (ja) 2013-02-06 2017-07-05 Ｎｃメディカルリサーチ株式会社 神経変性の治療のための不均質な骨髄細胞の亜集団を調製する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805913D0 (en) * 1998-03-19 1998-05-13 Kings College University Of Lo Diagnosis of ms
GB9620195D0 (en) * 1996-09-27 1996-11-13 King S College London Diagnosis and prevention of spongiform diseases

Also Published As

Publication number Publication date
MXPA01005158A (es) 2002-06-04
JP2002530679A (ja) 2002-09-17
AU764960B2 (en) 2003-09-04
CN1163755C (zh) 2004-08-25
NZ512335A (en) 2003-10-31
CA2350658A1 (en) 2000-06-02
WO2000031545A1 (en) 2000-06-02
CN1338053A (zh) 2002-02-27
GB9825948D0 (en) 1999-01-20
AU1286200A (en) 2000-06-13
EP1133696A1 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
Wildburger et al. Diversity of amyloid-beta proteoforms in the Alzheimer’s disease brain
Tailor et al. Mass spectrometric and functional aspects of drug–protein conjugation
BR9914373A (pt) Ensaio para conformação relacionada à doença de uma proteìna.
BRPI0112262B8 (pt) processo para detecção e teste para um marcador de uma doença conformacional, kit, processo para identificar um composto, processo para detectar a presença de uma forma patogênica prp sc de proteína de príon, e aparelho
MA29528B1 (fr) Agents de fixation
BR9808079A (pt) Uso de ressonância nuclear magnética unidimensional para identificar ligantes para biomoléculas alvos
BRPI0619357A8 (pt) Anticorpos monoclonais, composição farmacêutica, vacina, uso dos mesmos para tratamento ou prevenção de doença de alzheimer, métodos in vitro para diagnosticar e para identificar compostos apropriados para imunização de doença de alzheimer e kits
BR0014734A (pt) Método melhorado para detectar microorganismos resistentes a ácido na evacuação
De Ceuleneer et al. In vivo relevance of citrullinated proteins and the challenges in their detection
BRPI0611800A2 (pt) formulaÇço estÁvel de anticorpo
BR9906660A (pt) Processo para medir vìrus da hepatite c
BRPI0214872B8 (pt) unidade peptídica e multipeptídica, método ex vivo para detectar auto-anticorpos de pacientes sofrendo de artrite reumatoide e para seleção de um peptídeo adequado para o diagnóstico da referida doença, e kit de diagnóstico
BR0210568A (pt) Conjugado, uso de um conjugado, composição farmacêutica, e, método para tratar câncer em um mamìfero
NZ513454A (en) Methods of increasing erythropoietin in vivo
BR0113662C1 (pt) Sistema e método de análise de materiais e de geração de relátorios
BR9802494A (pt) Método para determinar a espessura de uma amostra ótica.
BR0008619A (pt) Método para preparar uma amostra de soro de sangue, e método para determinar a presença de prp^ sc^ no sangue
Person et al. An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS
WO2003006951A3 (en) System and method of determining proteomic differences
WO2003042659A3 (en) Rapid prion-detection assay
CA2364686A1 (en) Prion test
DK1261875T3 (da) Diagnostisk analyse for transmissibel spongiform encephalopati
BR9915695A (pt) Diagnóstico de doença desmielinizante ou espongiforme
SE8802944L (sv) Material foer lapptestning
WO2003106649A3 (en) CONJUGATE TEST AND USES THEREOF

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.